RxISK

Making Medicines Safer for All of Us

Drug Search by Year (Detail)

Side effect search by year (detail)

Drug:

Reaction: NO ADVERSE EVENT

20250101 - 20251231

No. 401 - 500

Next page: 6 next page>>
No.
safetyreportid
occurcountry
patientonsetage
patientsex 1:M 2:F
Adverse reaction
Drug (openfda.generic_name, medicinalproduct)
401
25119262
US
 2
No adverse event, Product use issue, Product dose omission issue,
DEXLANSOPRAZOLE,
402
25119278
US
No adverse event, Off label use,
403
25119684
US
 5
No adverse event, Product prescribing issue,
GUANFACINE,
404
25119734
US
 2
Off label use, No adverse event,
TRASTUZUMAB,
405
25119822
US
 44 2
Inappropriate schedule of product administration, No adverse event,
PEMBROLIZUMAB,
406
25119849
US
 40 2
Device breakage, Complication associated with device, Complication of device removal, No adverse event,
ETONOGESTREL,
407
25120013
US
No adverse event, Liquid product physical issue, Inappropriate schedule of product administration,
408
25120128
US
 49 1
Off label use, No adverse event,
TOCILIZUMAB, REMDESIVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG,
409
25120569
US
 2
Product prescribing issue, No adverse event,
PEMBROLIZUMAB,
410
25120611
US
 1
Product storage error, No adverse event,
411
25120745
US
 1
Product use issue, No adverse event,
PEMBROLIZUMAB, PEMBROLIZUMAB, NIVOLUMAB,
412
25120778
US
 76 2
Product dose omission issue, No adverse event,
PEMBROLIZUMAB,
413
25120896
US
 73 2
Off label use, No adverse event,
TOCILIZUMAB, TOCILIZUMAB,
414
25109993
US
 75 2
Drug delivery system malfunction, Wrong technique in product usage process, No adverse event, Device issue,
TOCILIZUMAB, TOCILIZUMAB,
415
25109996
US
 64 2
Accidental exposure to product, Product complaint, No adverse event,
TOCILIZUMAB,
416
25110060
US
Intercepted medication error, No adverse event,
TOCILIZUMAB,
417
25110064
US
 2
Drug effect less than expected, No adverse event,
TOCILIZUMAB,
418
25110066
US
 73 1
Intentional product misuse, Wrong technique in product usage process, No adverse event,
TOCILIZUMAB,
419
25110067
US
Product storage error, No adverse event,
ALTEPLASE,
420
25110085
US
Drug ineffective, No adverse event,
TOCILIZUMAB,
421
25110091
US
Product dose omission issue, No adverse event,
SITAGLIPTIN,
422
25110114
US
 2
Drug ineffective, No adverse event,
OMALIZUMAB, OMALIZUMAB,
423
25110116
US
Drug ineffective, No adverse event,
OMALIZUMAB,
424
25110117
US
 44 2
Intentional product misuse, No adverse event,
OMALIZUMAB,
425
25110121
US
Off label use, No adverse event,
OMALIZUMAB,
426
25110230
US
Off label use, No adverse event,
FARICIMAB, BEVACIZUMAB,
427
25110244
US
 2
Needle issue, Product dose omission issue, No adverse event,
OMALIZUMAB, OMALIZUMAB,
428
25110267
US
Drug ineffective, No adverse event,
OMALIZUMAB,
429
25110272
US
Intercepted product storage error, No adverse event,
OMALIZUMAB,
430
25110275
US
 12 1
No adverse event, Product dose omission issue, Needle issue, Device issue,
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, METHYLPHENIDATE HYDROCHLORIDE,
431
25110463
US
 67 2
Product dose omission issue, Wrong technique in device usage process, No adverse event,
432
25110502
US
 2
Drug ineffective, No adverse event,
FEXOFENADINE HYDROCHLORIDE,
433
25110506
US
 76 2
Accidental exposure to product, Off label use, No adverse event, Incorrect dose administered, Device defective, Wrong technique in product usage process,
TOCILIZUMAB,
434
25110507
US
 2
Device defective, No adverse event,
TOCILIZUMAB,
435
25110540
US
 64 2
Needle issue, Underdose, Exposure via skin contact, No adverse event,
TOCILIZUMAB,
436
25110555
US
 79
Drug dose omission by device, Wrong technique in product usage process, No adverse event,
ALBUTEROL SULFATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, THEOPHYLLINE, TIOTROPIUM BROMIDE, FLUTICASONE PROPIONATE,
437
25110561
US
Off label use, No adverse event,
OBINUTUZUMAB, OBINUTUZUMAB,
438
25110657
US
 1
Accidental underdose, Product complaint, Accidental exposure to product, Wrong technique in product usage process, No adverse event,
OMALIZUMAB,
439
25110762
US
 71 2
Off label use, Off label use, No adverse event,
BEVACIZUMAB,
440
25110802
US
Off label use, No adverse event,
OMALIZUMAB,
441
25110834
US
Product storage error, No adverse event,
RITUXIMAB,
442
25110838
US
Expired product administered, Device delivery system issue, No adverse event,
LEVALBUTEROL TARTRATE,
443
25110867
US
Off label use, No adverse event,
VEMURAFENIB,
444
25110938
US
Product prescribing error, Product substitution issue, Off label use, No adverse event,
MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE,
445
25110973
US
No adverse event, Product availability issue,
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE,
446
25111015
US
No adverse event, Off label use,
VEDOLIZUMAB,
447
25111034
US
Drug dose omission by device, Device delivery system issue, No adverse event,
ALBUTEROL SULFATE, ALBUTEROL SULFATE,
448
25111119
US
Drug dose omission by device, Circumstance or information capable of leading to device use error, No adverse event,
ALBUTEROL SULFATE,
449
25111156
US
Off label use, No adverse event,
RITUXIMAB,
450
25111198
US
 29 2
Off label use, No adverse event,
OMALIZUMAB,
451
25111211
US
 49 1
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
452
25111394
US
 49 1
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
453
25111589
US
Drug ineffective, No adverse event,
454
25111693
US
Off label use, No adverse event,
TENECTEPLASE,
455
25111845
US
 8 1
Off label use, No adverse event,
OMALIZUMAB,
456
25112173
US
 64 1
Product dispensing error, No adverse event,
OCRELIZUMAB,
457
25112222
US
 1
No adverse event,
BRIVARACETAM, BRIVARACETAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE),
458
25112223
US
 65 1
No adverse event,
BRIVARACETAM, BRIVARACETAM, CARBAMAZEPINE, OLANZAPINE,
459
25112305
US
 1
No adverse event,
BRIVARACETAM,
460
25112312
US
 2
No adverse event,
BRIVARACETAM, BRIVARACETAM,
461
25112384
US
 2
No adverse event,
BRIVARACETAM, BRIVARACETAM,
462
25112394
US
No adverse event,
BRIVARACETAM, BRIVARACETAM,
463
25112397
US
 1
No adverse event,
BRIVARACETAM,
464
25112692
US
 80 2
No adverse event,
PALBOCICLIB,
465
25113226
US
Device malfunction, No adverse event,
PEGFILGRASTIM-CBQV,
466
25113305
US
Device malfunction, No adverse event,
PEGFILGRASTIM-CBQV,
467
25113364
US
 2
Extra dose administered, No adverse event,
ALECTINIB HYDROCHLORIDE,
468
25113374
US
Device malfunction, No adverse event,
PEGFILGRASTIM-CBQV,
469
25113402
US
Device malfunction, No adverse event,
PEGFILGRASTIM-CBQV,
470
25113687
JP
 54 1
Overdose, Product use issue, No adverse event,
MOLNUPIRAVIR, MOLNUPIRAVIR,
471
25114071
US
 2
Exposure via eye contact, Product administered at inappropriate site, No adverse event,
EFINACONAZOLE,
472
25114983
HR
 28 2
Suicide attempt, No adverse event,
ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM,
473
25115131
GB
No adverse event,
DEXAMETHASONE,
474
25109174
US
Product dispensing error, No adverse event,
POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES,
475
25109228
US
 2
Off label use, No adverse event,
TOCILIZUMAB, MILNACIPRAN HYDROCHLORIDE,
476
25109279
US
 65 2
No adverse event,
INSULIN GLARGINE,
477
25109294
US
 25
Drug dose omission by device, Device delivery system issue, No adverse event,
LEVALBUTEROL TARTRATE, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, MONTELUKAST,
478
25109296
US
Drug dose omission by device, Wrong technique in product usage process, Device deposit issue, No adverse event,
ALBUTEROL SULFATE,
479
25109303
US
 64
Wrong technique in product usage process, Wrong technique in device usage process, No adverse event,
ALBUTEROL SULFATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN,
480
25109325
US
 91
Wrong technique in product usage process, No adverse event,
ALBUTEROL SULFATE, AMLODIPINE,
481
25109327
US
 63
Drug dose omission by device, Wrong technique in product usage process, Device deposit issue, Off label use, No adverse event,
ALBUTEROL SULFATE, ALBUTEROL SULFATE,
482
25109370
US
 2
Drug ineffective, No adverse event,
FEXOFENADINE HYDROCHLORIDE,
483
25109371
US
 67 2
Drug ineffective for unapproved indication, No adverse event,
LEVOCETIRIZINE DIHYDROCHLORIDE,
484
25109475
US
Recalled product administered, No adverse event,
RAMIPRIL,
485
25109528
US
 60 2
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
486
25109563
US
 35 2
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
487
25109653
US
 17
Off label use, No adverse event,
OMALIZUMAB,
488
25107705
DE
Device malfunction, No adverse event,
ENOXAPARIN SODIUM,
489
25107846
US
 57 2
Drug ineffective, No adverse event,
TOCILIZUMAB,
490
25107926
US
 1
Off label use, No adverse event,
EMICIZUMAB,
491
25107942
US
Intercepted product storage error, No adverse event,
DORNASE ALFA,
492
25108284
US
Maternal exposure during breast feeding, No adverse event,
SERTRALINE,
493
25108297
US
 75 2
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
494
25108419
US
 59 1
Product dose omission issue, No adverse event,
LETERMOVIR,
495
25108603
US
 35 1
Off label use, No adverse event,
OMALIZUMAB, OMALIZUMAB,
496
25108671
US
 63
Device issue, Drug dose omission by device, Wrong technique in product usage process, Off label use, Device deposit issue, No adverse event,
ALBUTEROL SULFATE, ALBUTEROL SULFATE,
497
25108673
US
 1
Prescription drug used without a prescription, No adverse event,
ALBUTEROL SULFATE,
498
25108679
US
Drug dose omission by device, Device use error, No adverse event,
ALBUTEROL SULFATE,
499
25108787
US
Product preparation issue, No adverse event,
OBINUTUZUMAB,
500
25108911
US
Off label use, No adverse event,
RANIBIZUMAB,

disclaimer

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

terms

https://open.fda.gov/terms/

license

https://open.fda.gov/license/

last_updated

2025-04-28

Next page: 6 next page>>